A Comparative Study of FV-100 vs. Valacyclovir for the Prevention of Post-Herpetic Neuralgia

Stopped early · Phase 3

Conditions studied: Shingles, Herpes Zoster, Postherpetic Neuralgia

In brief

This is a multicenter, randomized, double-blind, parallel-group, active controlled comparative study of the safety and efficacy of 2 dosing regimens of FV-100 versus valacyclovir administered for 7 days in subjects with uncomplicated AHZ(acute herpes zoster).

Key facts

Study ID

NCT02412917

Run by

ContraVir Pharmaceuticals, Inc.

People needed

237

Starts

2015-06-01

Expected to finish

2017-11-01

Last updated by the study team

2017-12-22

Who can join

Age: 30 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Receive a clinical diagnosis of uncomplicated AHZ as evidenced by a unilateral dermatomal rash
• Have zoster-related pain
• Are able to be randomized and receive their first dose within approximately 120 hours from appearance of rash

You may not qualify if…

• Have multidermal or disseminated AHZ
• Have facial, ophthalmologic or oral manifestations
• Have received Zostavax

Where it is running

• TX — Webster, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.